We have a new podcast from our Member Company, Merck & Co., Inc., on the value and implementation of a clinical QMS.
TransCelerate implores representatives for regulatory authorities to work with industry sponsors, in the spirit of ICH, to identify potential ways to re-harmonize global pharmacovigilance processes and requirements. Read it here.
In a recently published article, the Patient Technology Initiative describes the potential for patient-facing digital technologies to serve a variety of functions in clinical trials.
Explore TransCelerate's Knowledge Vault to become acquainted with the pioneering work that we deliver. Our multi-channel assets will educate you on our mission, core initiatives and provide you with useful tools.